Rhinoviruses in the pathogenesis of asthma

Current Allergy and Asthma Reports

Volumn 3, Issue 2, 2003, Pages 137-145

  Papadopoulos, Nikolaos G ^a   Psarras, Stelios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 16; INTERLEUKIN 6; INTERLEUKIN 8; RANTES;

AIRWAY OBSTRUCTION; ASTHMA; ATOPY; BRONCHUS MUCOSA; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; HUMAN; HUMAN RHINOVIRUS; IN VIVO STUDY; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG ALVEOLUS EPITHELIUM; PATHOGENESIS; PHENOTYPE; REVIEW; SENSITIVITY ANALYSIS; TH2 CELL; UPPER RESPIRATORY TRACT; VIRUS IDENTIFICATION; VIRUS INFECTION; BRONCHUS HYPERREACTIVITY; COMMON COLD; IMMUNOLOGY; PATHOGENICITY; RESPIRATORY TRACT INFECTION; RHINOVIRUS; T LYMPHOCYTE; VIROLOGY;

ASTHMA; BRONCHIAL HYPERREACTIVITY; COMMON COLD; HUMANS; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS; T-LYMPHOCYTES;

EID: 0038205423     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-003-0026-5     Document Type: Review

References (84)

1. Tyrrell DAJ: A collaborative study of the aetiology of acute respiratory infections in Britain 1961-1964: a report of the Medical Research Council Working Party on acute respiratory virus infections. Br Med J 1965, 2:319-326.
2. Mertsola J, Ziegler T, Ruuskanen O, et al.: Recurrent wheezy bronchitis and viral respiratory infections [see comments]. Arch Dis Child 1991, 66:124-129.
3. Johnston SL, Pattemore PK, Sanderson G, et al.: Community study of role of viral infections in exacerbations of asthma in 9- to 11-year-old children. Br Med J 1995, 310:1225-1228.
4. Nicholson KG, Kent J, Ireland DC: Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993, 307 982-986.
5. Johnston SL, Pattemore PK, Sanderson C, et al.: The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996, 154:654-660.
6. Freymuth F, Vabret A, Brouard J, et al.: Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 1999, 13 131-139.
7. Teichtahl H, Buckmaster N, Pertnikovs E: The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997, 112:591-596.
8. Atmar RL, Guy E, Guntupalli KK, et al.: Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998, 158:2453-2459.
9. Papadopoulos NG, Johnston SL: The role of viruses in the induction and progression of asthma. Curr Allergy Asthma Rep 2001, 1:144-152.
10. Fraenkel DJ, Bardin PG, Sanderson G, et al.: Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med 1995, 151:879-886.
11. Gern JE, Vrtis R, Grindle KA, et al.: Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000, 162:2226-2231.
12. Grunberg K, Smits H, Timmers M, et al.: Experimental rhinovirus 16 infection: effects on cell differentials and soluble markers in sputum in asthmatic subjects. Am J Respir Crit Care Med 1997, 156:609-616.
13. Grunberg K, Timmers MC, de Klerk ET, et al.: Experimental rhinovirus 16 infection causes variable airway obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999, 160:1375-1380.
14. Gern J, Calhoun W, Swenson C, et al.: Rhinovirus infection preferentially increases lower airway responsiveness in allergic subjects. Am J Respir Crit Care Med 1997, 155: 872-1876.
15. Bardin PG, Fraenkel DJ, Sanderson G, et al.: Peak expiratory flow changes during experimental rhinovirus infection. Eur Respir J 2000, 16:980-985.
16. Avila PC, Abisheganaden JA, Wong H, et al.: Effects of allergic inflammation of the nasal mucosa on the severity of rhinovirus 16 cold [see comments]. J Allergy Clin Immunol 2000, 105:923-932.
17. Fleming HE, Little FF, Schnurr D, et al.: Rhinovirus-16 colds in healthy and in asthmatic subjects: similar changes in upper and lower airways. Am J Respir Crit Care Med 1999, 160:100-108.
18. Cheung D, Dick E,Timmers M, et al.: Rhinovirus inhalation causes long-lasting excessive airway narrowing in response to methacholine in asthmatic subjects in vivo. Am J Respir Crit Care Med 1995, 152:1490-1496.
19. Skoner D, Doyle W, Seroky J, et al.: Lower airway responses to rhinovirus 39 in healthy allergic and nonallergic subjects. Eur Respir J 1996, 9:1402-1406.
20. Wedzicha JA: Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002, 121:136S-141S.
21. Seemungal TA, Harper-Owen R, Bhowmik A, et al.: Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000, 16: 77-683
22. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161:1501-1507.
23. Papadopoulos NG, Moustaki M, Tsolia M, et al.: Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med 2002, 165: 1285-1289.
24. Xepapadaki F, Papadopoulos NG, Bossios A, et al.: Airway hyperresponsiveness in atopic and atopic-asthmatic children following respiratory tract infections [abstract]. Allergy 2002, 57(Suppl 73):295-296.
25. Corne JM, Marshall C, Smith S, et al.: Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002, 359:831-834.
26. Bardin P, Fraenkel D, Sanderson G, et al.: Amplified rhinovirus colds in atopic subjects. Clin Exp Allergy 1994, 24:457-464.
27. Papadopoulos NG, Stanciu LA, Papi A, et al.: A defective type 1 response to rhinovirus in atopic asthma. Thorax 2002, 57:328-332.
28. Killington RA, Stott EJ, Lee D: The effect of temperature on the synthesis of rhinovirus type 2 RNA. J Gen Virol 1977, 36:403-411.
29. Papadopoulos NG, Sanderson G, Hunter J, Johnston SL: Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol 1999, 58:100-104.
30. Gern JE, Galagan DM, Jarjour NN, et al.: Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997, 155:1159-1161.
31. Papadopoulos NG, Bates PJ, Bardin PG, Papi A, et al.: Rhinoviruses infect the lower airways. J Infect Dis 2000, 181:1875-1884.
32. Bardin PG, Johnston SL, Sanderson C, et al.: Detection of rhinovirus infection of the nasal mucosa by oligonucleotide in situ hybridization. Am J Respir Cell Mol Biol 1994, 10: 07-213.
33. Mosser AG, Brockman-Schneider R, Amineva S, et al.: Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium. J Infect Dis 2002, 185:734-743.
34. Ying S, Meng Q, Zeibecoglou K, et al.: Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 [MCP-3], and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999, 163:6321-6329.
35. Teran LM, Johnston SL, Schrøder JM, et al.: Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am J Respir Crit Care Med 1997, 155:1362-1366.
36. Mashikian MV, Tarpy RE, Saukkonen JJ, et al.: Identification of IL-16 as the lymphocyte chemotactic activity in the bronchoalveolar lavage fluid of histamine-challenged asthmatic patients. J Allergy Clin Immunol 1998, 101:786-792.
37. Einarsson O, Geba G, Zhu Z, et al.: Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996, 97: 15-924.
38. Psarras S, Xatzipsalti M, Volonaki E, et al.: Rhinovirus infection stimulates production of fibroblast growth factor-2 by airway epithelial and stromal cells [abstract]. Allergy 2002, 57(Suppl 73):296.
39. Greiff L, Andersson M, Andersson E, et al.: Experimental common cold increases mucosal output of eotaxin in atopic individuals. Allergy 1999, 54:1204-1208.
40. van Benten JJ, KleinJan A, Neijens HJ, et al.: Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 2001, 56:949-956.
41. Greiff L, Andersson M, Svensson C, et al.: Allergen challenge-induced acute exudation of IL-8, ECP and alpha2-macroglobulin in human rhinovirus-induced common colds. Eur Respir J 1999, 13:41-47.
42. Ferreira A, Williams Z, Donninger H, et al.: Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12. Respiration 2002, 69:136-142.
43. Yuta A, Doyle WJ, Gaumond E, et al.: Rhinovirus infection induces mucus hypersecretion. Am J Physiol 1998, 274:L1017-1023.
44. Zhu Z, Tang W, Ray A, et al.: Rhinovirus stimulation of interleukin-6 in vivo and in vitro: evidence for nuclear factor kappa b-dependent transcriptional activation. J Clin Invest 1996, 97:421-430.
45. Zhu Z, Tang W, Gwaltney JMJ, et al.: Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappab. Am J Physiol 1997, 273:L814-824.
46. Proud D, Gwaltney JMJ, Hendley J, et al.: Increased levels of interleukin-1 are detected in nasal secretions of volunteers during experimental rhinovirus colds. J Infect Dis 1994, 169: 007-1013.
47. Jarjour NN, Gern JE, Kelly EA, et al.: The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol 2000, 105:1169-1177.
48. Schroth MK, Grimm E, Frindt P, et al.: Rhinovirus replication causes rantes production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 1999, 20:1220-1228.
49. Piedimonte G, Rodriguez MM, King KA, et al.: Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 1999, 277:L831-840.
50. Joos GF, Germonpre PR, Pauwels RA: Neural mechanisms in asthma. Clin Exp Allergy 2000, 30(Suppl 1):60-65.
51. Papadopoulos N, Papi A, Bossios A, et al.: Rhinovirus infection upregulates neuropeptide-receptor mRNA expression and synergizes with neuropeptides in cytokine production by bronchial epithelial cells [abstract]. Am J Resp Clin Care Med 2001, 163:A549.
52. Shibayama Y, Skoner D, Suehiro S, et al.: Bradykinin levels during experimental nasal infection with rhinovirus and attenuated influenza virus. Immunopharmacology 1996, 33:311-313.
53. Kharitonov SA, Yates D, Barnes PJ: Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995, 8:295-297.
54. de Gouw HW, Grunberg K, Schot R, et al.: Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur Respir J 1998, 11:126-132.
55. Sanders SP, Siekierski ES, Porter JD, et al.: Nitric oxide inhibits rhinovirus-induced cytokine production and viral replication in a human respiratory epithelial cell line. J Virol 1998, 72:934-942.
56. Sanders SP, Kim J, Connolly KR, et al.: Nitric oxide inhibits rhinovirus-induced granulocyte macrophage colony-stimulating factor production in bronchial epithelial cells. Am J Respir Cell Mol Biol 2001, 24:317-325.
57. Sanders SP, Siekierski ES, Richards SM, et al.: Rhinovirus infection induces expression of type 2 nitric oxide synthase in human respiratory epithelial cells in vitro and in vivo. J Allergy Clin Immunol 2001, 107:235-243.
58. Kaul P, Singh I, Turner RB: Effect of nitric oxide on rhinovirus replication and virus-induced interleukin-8 elaboration. Am J Respir Crit Care Med 1999, 159:1193-1198.
59. Grunstein MM, Hakonarson H, Whelan R, et al.: Rhinovirus elicits pro-asthmatic changes in airway responsiveness independently of viral infection. J Allergy Clin Immunol 2001, 108:997-1004.
60. Grunstein MM, Hakonarson H, Hodinka RE, et al.: Mechanism of cooperative effects of rhinovirus and atopic sensitization on airway responsiveness. Am J Physiol Lung Cell Mol Physiol 2001, 280:L229-238.
61. Hakonarson H, Maskeri N, Carter C et al.: Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness. J Clin Invest 1998, 102:1732-1741.
62. Billington CK, Pascual RM, Hawkins ML, et al.: Interleukin-1b and rhinovirus sensitize adenylyl cyclase in human airway smooth-muscle cells. Am J Respir Cell Mol Biol 2001, 24: 33-639.
63. Greve JM, Davis G, Meyer AM, et al.: The major human rhinovirus receptor is ICAM-1. Cell 1989, 56:839-847.
64. Papi A, Johnston SL: Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappab-mediated transcription. J Biol Chem 1999, 274:9707-9720.
65. Grunberg K, Sharon RF, Hiltermann TJ, et al.: Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin Exp Allergy 2000, 30: 015-1023.
66. Suzuki T, Yamaya M, Kamanaka M, et al.: Type 2 rhinovirus infection of cultured human tracheal epithelial cells: role of LDL receptor. Am J Physiol Lung Cell Mol Physiol 2001, 280: 409-L420.
67. Handzel ZT, Busse WW, Sedgwick JB, et al.: Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol 1998, 160:1279-1284.
68. Gern JE, Dick EC, Lee WM, et al.: Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 1996, 156:621-627.
69. Alper CM, Doyle WJ, Skoner DP, et al.: Prechallenge antibodies moderate disease expression in adults experimentally exposed to thinovirus strain hanks. Clin Infect Dis 1998, 27: 19-128.
70. Grunberg K, Sharon RF, Sont JK, et al.: Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001, 164:1816-1822.
71. Gern J, Vrtis R, Kelly E, et al.: Rhinovirus produces nonspecific activation of lymphocytes through a monocyte-dependent mechanism. J Immunol 1996, 157: 605-1612.
72. Gern J, Joseph B, Galagan D, et al.: Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism. J Infect Dis 1996, 174:1143-1150.
73. Parry DE, Busse WW, Sukow KA, et al.: Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol 2000, 105: 92-698.
74. Bianco A, Sethi SK, Allen JT, et al.: Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J 1998, 12:619-626.
75. Papadopoulos NG, Stanciu LA, Papi A, et al.: Rhinovirus-induced alterations on peripheral blood mononuclear cell phenotype and costimulatory molecule expression in normal and atopic asthmatic subjects. Clin Exp Allergy 2002, 32:537-542.
76. Stockl J, Vetr H, Majdic O, et al.: Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10. J Clin Invest 1999, 104:957-965.
77. Papi A, Stanciu LA, Papadopoulos NG, et al.: Rhinovirus infection induces HLA class I , but not class II, and costimulatory molecules upregulation on respiratory epithelial cells. J Infect Dis 2000, 181:1780-1784.
78. Papadopoulos NG, Papi A, Meyer J, et al.: Rhinovirus infection upregulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy 2001, 31:1060-1066.
79. Schroth MK, Grimm E, Frindt F, et al.: Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Resp Cell Mol Biol 1999, 20:1220-1228.
80. Griego SD, Weston CB, Adams JL, et al.: Role of p38 mitogen-activated protein kinase in rhinovirus-induced cytokine production by bronchial epithelial cells. J Immunol 2000, 165:5211-5220.
81. Kim J, Sanders SP, Siekierski ES, et al.: Role of NF-kappa b in cytokine production induced from human airway epithelial cells by rhinovirus infection. J Immunol 2000, 165: 384-3392.
82. Subauste MC, Jacoby DB, Richards SM, Proud D: Infection of a human respiratory epithelial cell line with rhinovirus: induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995, 96:549-557.
83. Johnston SL, Papi A, Bates PJ, et al.: Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol 1998, 160:6172-6181.
84. Konno S, Grindle KA, Lee WM, et al.: Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cells. Am J Respir Cell Mol Biol 2002, 26: 94-601.